South America Closed System Drug Transfer Device Market

ID: MRFR/MED/47919-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
South America Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), By End-users (Hospitals & Clinics, Specialty Centers, Others), and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Closed System Drug Transfer Device Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)10.08%
2024 Market Size$ 120 Million
2025 Market Size$ 132.1 Million
2035 Market Size$ 345 Million

Key Players

Baxter International Inc
B. Braun Melsungen AG
Cardinal Health Inc
Cypress Medical Products LLC
ICU Medical Inc
Merit Medical Systems Inc
Trends
  • Increased Regulatory Focus
  • Technological Advancements
  • Rising Demand for Safety
Opportunities
  • Growing Healthcare Expenditure
  • Rising Awareness of Drug Safety
  • Government Initiatives and Support
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Oncology
      2. 4.1.2 Non-Oncology
      3. 4.1.3 Palliative Care
      4. 4.1.4 Emergency Care
    2. 4.2 Healthcare, BY End Use (USD Million)
      1. 4.2.1 Hospitals
      2. 4.2.2 Home Healthcare
      3. 4.2.3 Pharmacies
      4. 4.2.4 Specialty Clinics
    3. 4.3 Healthcare, BY Product Type (USD Million)
      1. 4.3.1 Syringe Systems
      2. 4.3.2 Bag Systems
      3. 4.3.3 Vial Systems
      4. 4.3.4 Transfer Devices
    4. 4.4 Healthcare, BY Material Type (USD Million)
      1. 4.4.1 Plastic
      2. 4.4.2 Glass
      3. 4.4.3 Metal
      4. 4.4.4 Composite
    5. 4.5 Healthcare, BY Distribution Channel (USD Million)
      1. 4.5.1 Direct Sales
      2. 4.5.2 Distributors
      3. 4.5.3 Online Sales
      4. 4.5.4 Retail
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Baxter International (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 B. Braun Melsungen AG (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Cardinal Health (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Fresenius Kabi (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 C.R. Bard (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Terumo Corporation (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Medline Industries (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Smiths Medical (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Halyard Health (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY END USE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE
    6. 6.6 SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY END USE, 2026-2035 (USD Million)
      3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
      4. 7.2.4 BY MATERIAL TYPE, 2026-2035 (USD Million)
      5. 7.2.5 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South America South America Closed System Drug Transfer Device Market Segmentation

South America Closed System Drug Transfer Device Market By Application (USD Million, 2022-2035)

  • Oncology
  • Non-Oncology
  • Palliative Care
  • Emergency Care

South America Closed System Drug Transfer Device Market By End Use (USD Million, 2022-2035)

  • Hospitals
  • Home South America Closed System Drug Transfer Device Market
  • Pharmacies
  • Specialty Clinics

South America Closed System Drug Transfer Device Market By Product Type (USD Million, 2022-2035)

  • Syringe Systems
  • Bag Systems
  • Vial Systems
  • Transfer Devices

South America Closed System Drug Transfer Device Market By Material Type (USD Million, 2022-2035)

  • Plastic
  • Glass
  • Metal
  • Composite

South America Closed System Drug Transfer Device Market By Distribution Channel (USD Million, 2022-2035)

  • Direct Sales
  • Distributors
  • Online Sales
  • Retail

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035